The JAMA Psychiatry cohort study evaluates the role of cigarette smoking transitions in long-term recovery from substance use disorders (SUDs), offering vital insights for clinicians, treatment programs, and addiction researchers. Using data from the nationally representative PATH Study, researchers followed 2,652 adults with a history of SUD across multiple years to understand whether changing smoking behavior — specifically quitting cigarettes — is associated with sustained recovery from other addictive substances. 

On December 1, 2025, the SUPPORT for Patients and Communities Reauthorization Act of 2025 was signed into law, extending critical federal substance use disorder (SUD) prevention, treatment, and recovery programs through fiscal year 2030. This bipartisan legislative achievement, passed overwhelmingly in the House and by unanimous consent in the Senate, reaffirms Congress’s commitment to combating the opioid and broader SUD crisis that continues to devastate communities nationwide.

The Guardian’s December 28, 2025 analysis highlights an emerging public health contributor to the historic decline in U.S. overdose deaths: expanded Crisis Intervention Training (CIT) for law enforcement, emphasizing evidence-informed, compassionate responses to substance use disorders. Since late 2023, national overdose mortality has fallen, reflecting broader progress seen in provisional CDC data showing significant decreases in drug overdose fatalities. 

In 2024, U.S. states and localities began spending opioid settlement funds — payments from companies implicated in the opioid crisis — to address addiction and overdose harms. These settlements, part of a broader national effort totaling more than $50 billion, offer an unprecedented but complex opportunity to strengthen systems of care. Researchers from KFF Health News, the Johns Hopkins Bloomberg School of Public Health, and Shatterproof catalogued over 10,500 individual expenditures in 2024, revealing how jurisdictions have allocated nearly $2.7 billion of settlement cash.

ARMR Sciences is preparing to launch the first major human clinical trial of a fentanyl vaccine, marking a potentially transformative development in efforts to prevent opioid overdose and reduce mortality linked to synthetic opioids. Unlike medications such as naloxone that reverse overdoses after they occur, this investigational vaccine is designed as a preventive intervention, training the immune system to produce antibodies that bind to fentanyl molecules in the bloodstream.

ARMR Sciences is preparing to launch the first major human clinical trial of a fentanyl vaccine, marking a potentially transformative development in efforts to prevent opioid overdose and reduce mortality linked to synthetic opioids. Unlike medications such as naloxone that reverse overdoses after they occur, this investigational vaccine is designed as a preventive intervention, training the immune system to produce antibodies that bind to fentanyl molecules in the bloodstream.

Senior living communities are beginning to explore how artificial intelligence can enhance daily life, and dining is becoming an unexpected area of innovation. One example highlighted by Argentum is a Florida-based community piloting an AI-supported menu planning concept known as “365 in the 305.” Instead of relying on a traditional rotating cycle of repeated meals, the culinary team is now using AI tools to develop a completely new menu for each day of the year—bringing more variety, creativity, and excitement to mealtime.

Senior living operators are increasingly looking to technology to enhance everyday experiences, and dining has emerged as a promising area for innovation. A recent example highlighted by Argentum features a Florida-based senior living community implementing an AI-supported dining concept known as “365 in the 305.” The initiative replaces traditional rotating menus with a system that produces a different menu for every day of the year, offering residents greater variety and engagement at mealtimes.

On August 8, 2025, Illinois became the first U.S. state to formally restrict AI from delivering therapeutic or diagnostic services under the Wellness and Oversight for Psychological Resources (WOPR) Act. By banning unlicensed AI “therapists” and setting fines up to $10,000, the law draws a critical distinction between wellness tools and clinical practice—ensuring patients receive guidance only from qualified professionals. 

What the WOPR Act Does 

Senior living marketing isn’t about amenities anymore — it’s about connection. A recent Eldercare Review feature shows how communities are using digital outreach, personalized messaging, and a wellness-first mindset to reach today’s tech-savvy seniors and their families.

Social storytelling, virtual open houses, targeted email campaigns, and mobile-friendly content are becoming the norm. Innovation plays a role too, with marketing highlighting wearable tech, telemedicine access, and safety systems that reassure families and support resident well-being.